Cordis is involved in providing medical devices and solutions for various healthcare applications, self-described as a leader in the cardiovascular and endovascular space.

Cordis

Cordis Shape Up

Cordis Catalogue

CORDIS Diagnostic Catheters

Domain Not Resolving

Google Tag Manager

Google Font API

DNSSEC

Global Site Tag

Font Awesome

DoubleClick.Net

Cloudflare CDN

US Privacy User Signal Mechanism

Cloudflare Hosting

Owner

Barb Scheitlin Smith

Chief Financial Officer

Christopher Scully

Legal

Aaron Lewis

Business Management

Alberto Paret

Director - Finance, Innovation and M&A

Alexandra Smith

Operations

Allen Wan

Director, Payer Relations

Ann Thompson

Sales and Support

Anthony Mineo

Aqeel Qureshi

Director, Corporate Accounts

Bert Kosup

Scott Drake

George Adams

Chief Medical Officer

Nusrath Sultana

Head of Clinical and Medical Affairs

William P. Murphy Jr.

Founder

Alan Tsai

BU Director

General Manager

Florida Companies With More Than 1000 Employees

East Coast Companies With More Than 1000 Employees

East Coast Acquired Companies With More Than 500 Employees

Medical Acquired Companies With More Than $1M in Revenue

Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease. Technological innovation and a deep understanding of the medical marketplace and the needs of patients have made Cordis the world's leading developer and manufacturer of breakthrough stents, catheters and guidewires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology.

Hialeah

Florida

United States

North America

Cordis receives FDA approval for MYNX CONTROL™ VENOUS Vascular Closure Device

Cordis Auckland has new boss: Craig Bonnor succeeds Franz Mascarenhas

Cordis Appoints Scott Drake as New Leader

Cordis Announces Scott Drake as Chief Executive Officer

Cordis issues statement on the CMS announcement to expand coverage of carotid stenting

Medtech firm Cordis acquires Swiss-based MedAlliance, adds drug-eluting balloon to its product line

Cordis completes $1B+ Medalliance buy heavily weighted toward future milestones

Cordis Completes the up to $1.13B Deal for MedAlliance

Cordis Announces the Completed Acquisition of MedAlliance

A balloon catheter designed for controlled and sustained release of sirolimus to treat vascular disease.

A guiding catheter used to provide support during vascular procedures.

A device used for vascular closure that integrates active sealing and resorbability.

A thin-walled introducer with elastomeric properties designed to maintain lumen integrity.

A sheathless access system that reduces access size and is compatible with various guiding catheters.

India

Asia

Switzerland

Europe

Canada

Brazil

South America

HTML5

Office 365

Apache Server

F5 NGINX

Comodo PositiveSSL Certificates

Microsoft Outlook

Google Compute Engine

jQuery

Akamai Intelligent Platform

Bootstrap

Cordis owns Cordis Endovacular

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 25, 2024 12:09 AM	cf1b4525
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 25, 2024 12:09 AM	d625ecd8
crunchbase trigger	general	Dec 4, 2024 8:54 AM	ff895207
crunchbase profile	general	Dec 4, 2024 1:28 PM	31e553c1
li profile	general
translate crunchbase fundingrounds	general	Dec 4, 2024 1:59 PM	7f6cd17f
peers	general	Oct 25, 2024 12:09 AM	39ce6a57
news basic	general	Oct 25, 2024 12:09 AM	2eece6fc
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:CORDIS

Cordis